Omar A. Abed

20212022202320241 3 12 1

Public access

3 articles

0 articles

available

not available

Based on funding mandates

David NielsenArizona State UniversityVerified email at asu.edu
James MoonJ. G. Searle Professor, Pharmaceutical Sciences and Biomedical Engineering, University of MichiganVerified email at umich.edu
Xuan WangAssociate Professor, Arizona State UniversityVerified email at asu.edu
Gavin KurganBioinformatician, Integrated DNA TechnologiesVerified email at idtdna.com
Kai HanChina Pharmaceutical University; University of Michigan; Wuhan UniversityVerified email at cpu.edu.cn

Omar A. Abed

Verified email at umich.edu


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Characterizing Escherichia coli’s transcriptional response to different styrene exposure modes reveals novel toxicity and tolerance insights M Machas, G Kurgan, OA Abed, A Shapiro, X Wang, D Nielsen Journal of Industrial Microbiology and Biotechnology 48 (1-2), kuab019, 2021	8	2021
Emerging nanotechnologies and microbiome engineering for the treatment of inflammatory bowel disease OA Abed, Y Attlassy, J Xu, K Han, JJ Moon Molecular pharmaceutics 19 (12), 4393-4410, 2022	7	2022
Vaccines for immune tolerance against autoimmune disease A Kim, F Xie, OA Abed, JJ Moon Advanced Drug Delivery Reviews, 115140, 2023	1	2023
Applying a ‘Metabolic Funnel’ for Phenol Production in Escherichia coli B Thompson, M Machas, O Abed, DR Nielsen Fermentation 7 (4), 216, 2021	1	2021

The system can't perform the operation now. Try again later.

Articles 1–4

Citations per year